Previously published data suggest that FANCD2 and FANCJ knockdown in HNSCC cell lines enhances aggressive cancer phenotypes, such as epithelial-to-mesenchymal (EMT)-like morphological changes and increased invasion, at least in part due to metabolic dysregulation [24,25,26]. The gene discussed is FANCD2; the disease is cancer.